Inactive Instrument

Insiders Harpoon Therapeutics, Inc.

Equities

HARP

US41358P2056

Insiders

Unlock all the news: Be the first to know and act before the market!

Harpoon Therapeutics Appoints Chief Legal Officer, Chief People Officer	Dec. 26	MT
Harpoon Therapeutics, Inc. Announces Board Changes	Dec. 26	CI
Harpoon Therapeutics, Inc. Appoints Haibo Wang as Senior Vice President of Business Development	23-08-01	CI
Insider Buy: Harpoon Therapeutics	23-03-28	MT
Harpoon Therapeutics, Inc. Appoints Luke Walker, M.D., as Chief Medical Officer	22-10-04	CI
Harpoon Therapeutics Appoints Lauren Silvernail to Board of Directors	22-09-19	CI
Harpoon Therapeutics, Inc. Announces Resignation of Georgia L. Erbez as Chief Financial Officer, Effective August 31, 2022	22-08-10	CI
Harpoon Therapeutics, Inc. Announces Executive Appointments	22-07-06	CI
Harpoon Therapeutics Chief Medical Officer Natalie Sacks to Leave in June -- Shares Drop in Pre-Market Trading	22-04-08	MT
Harpoon Therapeutics Chief Medical Officer Natalie Sacks to Leave in June	22-04-07	MT
Natalie Sacks to Leave Harpoon Therapeutics, Inc. as Chief Medical Officer, Effective June 1, 2022	22-04-07	CI
Harpoon Therapeutics Names Julie Eastland as CEO, Scott Myers as Chairman	21-10-27	MT
Harpoon Therapeutics, Inc. Announces Executive Changes	21-10-26	CI
Harpoon Therapeutics, Inc. Announces Executive Changes	21-10-26	CI
Harpoon Therapeutics Appoints Alan Colowick to Board of Directors	21-03-24	CI
Harpoon Therapeutics Announces Changes to Board of Directors	20-07-02	CI
Harpoon Therapeutics, Inc. Announces Board Appointments	20-04-17	CI
Harpoon Therapeutics, Inc. Appoints Two New Members to Its Board of Directors	20-04-01	CI
Harpoon Therapeutics, Inc. Announces Management Changes	18-10-30	CI
Harpoon Therapeutics Appoints Julie Eastland to Its Board of Directors	18-10-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Harpoon Therapeutics, Inc.

Equities

HARP

US41358P2056

Insiders

Filters